Eli Lilly"s Trulicity shows promise in delivering efficacy in type 2 diabetes

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

read more.....»»

read more.....»»

Eli Lilly and Co raised the top-end of its 2020 profit forecast on Thursday and reported better-than-expected quarterly results, as customers stocking up medicines such as diabetes drug Trulicity during the coronavirus pandemic boosted sales......»»

Eli Lilly and Co raised the top-end of its 2020 profit forecast on Thursday and beat quarterly estimates, benefiting from customers stocking up medicines such as diabetes drug Trulicity amid the coronavirus pandemic......»»

Eli Lilly and Co beat quarterly profit estimates and raised the top-end of its 2020 earnings forecast on Thursday, benefiting from customers stockpiling on medicines such as its diabetes treatment Trulicity amid the coronavirus pandemic......»»

Eli Lilly and Co reported a 15.1% rise in first-quarter sales on Thursday, boosted by higher sales of its top-selling diabetes drug Trulicity and also benefiting from customers stockpiling its medicines amid the coronavirus pandemic......»»

A generic vaccine that's shown promise in reversing type 1 diabetes long-term in trials at Massachusetts General Hospital will soon have a new target: the COVID-19 coronavirus......»»

Eli Lilly and Co third-quarter sales missed Wall Street estimates on Wednesday as rebates limited revenue from its top-selling diabetes drug Trulicity, and its shares fell about 4%......»»

Eli Lilly and Co's quarterly sales missed Wall Street estimates on Wednesday as the drugmaker offered more discounts or rebates for its top-selling diabetes drug Trulicity, sending shares down 3%......»»

Eli Lilly and Co beat analysts' estimates for quarterly profit and raised its full-year earnings forecast on Tuesday, as higher sales of diabetes drugs Trulicity and Basaglar offset competition for its erectile dysfunction treatment, Cialis......»»

Eli Lilly and Co beat analysts' estimates for quarterly profit on Tuesday and raised its full-year earnings forecast, as higher sales of diabetes drugs Trulicity and Basaglar offset competition for its erectile dysfunction drug, Cialis......»»

Eli Lilly and Co edged past Wall Street estimates for quarterly revenue on Tuesday, as higher sales of its top-selling diabetes drug, Trulicity, helped offset the impact of generic competition on its erectile dysfunction drug, Cialis......»»

Large-cap pharma Eli Lilly And Co (NYSE: LLY) has pulled back significantly from its late-March intra-day high of $132.13. The company issued updates on heart failure and diabetes drugs Wednesday.  read more.....»»

Shares of Eli Lilly & Co. fell 2.4% in premarket trade on Monday after a randomized control trial showed that diabetes drug .....»»

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Eli Lilly and Co reported lower-than-expected sales for its top-selling diabetes drug Trulicity on Tuesday and said it expects further hits from price declines in the United States, sending its shares down 3 percent......»»

Eli Lilly and Co reported lower-than-expected sales for its top-selling diabetes drug Trulicity and cut its full-year revenue forecast as it sees further hits from price declines in the United States, sending its shares down 3 percent......»»

Researchers at Georgia Tech found a way to bypass rejection of pancreatic cell transplants by encasing them in a hydrogel shield. Could this challenge the future of insulin injections?Related Stocks: NVO, SNY, LLY, MESO,.....»»